Citius Pharmaceuticals, Inc. Repayments of Related Party Debt
Citius Pharmaceuticals, Inc. (CTXR) reported Repayments of Related Party Debt of $300.00 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2025-12-23
- Citius Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2025-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2014-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2013-12-31 was $0.00.
- Citius Pharmaceuticals, Inc. repayments of related party debt for the quarter ending 2013-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. repayments of related party debt for fiscal 2025 was $300.00K.
- Citius Pharmaceuticals, Inc. repayments of related party debt for fiscal 2013 was $0.00.
- Citius Pharmaceuticals, Inc. repayments of related party debt for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Citius Pharmaceuticals, Inc. repayments of related party debt for fiscal 2011 was $8.75K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 13 month | Repayments of Related Party Debt 16 month | Repayments of Related Party Debt 19 month | Repayments of Related Party Debt 22 month | Repayments of Related Party Debt 25 month | Repayments of Related Party Debt 28 month | Repayments of Related Party Debt 31 month | Repayments of Related Party Debt 34 month | Repayments of Related Party Debt 37 month | Repayments of Related Party Debt 40 month | Repayments of Related Party Debt 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $300.00K 10-K · filed 2025-12-23 | |||||||||||||
| 2025-06-30 | $300.00K 10-Q · filed 2025-08-12 | ||||||||||||||
| 2014-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $8.75K 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | $0.00 10-Q · filed 2014-02-19 | $0.00 derived: sum of 2 quarters · filed 2014-02-19 | $0.00 derived: sum of 3 quarters · filed 2014-02-19 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $8.75K 10-Q · filed 2014-02-19 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $0.00 derived: sum of 2 quarters · filed 2014-02-06 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 10-K · filed 2014-02-06 | $8.75K 10-K · filed 2014-02-06 | ||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-18 | $0.00 derived: sum of 2 quarters · filed 2014-05-15 | $0.00 10-Q · filed 2013-09-18 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $8.75K 10-Q · filed 2013-09-18 | ||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-15 | $0.00 10-Q · filed 2014-05-15 | $0.00 derived: sum of 3 quarters · filed 2014-05-15 | $0.00 derived: sum of 4 quarters · filed 2014-05-15 | $8.75K 10-Q · filed 2013-05-13 | ||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-19 | $0.00 derived: sum of 2 quarters · filed 2014-02-19 | $0.00 derived: sum of 3 quarters · filed 2014-02-19 | $0.00 derived: sum of 4 quarters · filed 2014-02-19 | $8.75K 10-Q · filed 2013-02-08 | ||||||||||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $0.00 derived: sum of 2 quarters · filed 2014-02-06 | $0.00 derived: sum of 3 quarters · filed 2014-02-06 | $0.00 10-K · filed 2014-02-06 | $8.75K 10-K · filed 2013-01-15 | ||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-18 | $0.00 derived: sum of 2 quarters · filed 2013-09-18 | $0.00 10-Q · filed 2013-09-18 | $8.75K 10-Q · filed 2012-08-17 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-13 | $0.00 10-Q · filed 2013-05-13 | $8.75K 10-Q · filed 2012-05-11 | ||||||||||||
| 2011-12-31 | $0.00 10-Q · filed 2013-02-08 | $8.75K 10-Q · filed 2012-02-14 | |||||||||||||
| 2011-09-30 | $8.75K 10-K · filed 2013-01-15 | $8.75K 10-K · filed 2012-01-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |